Patrimoine de marque : le passé au service du management de la marque

Researchers and practitioners talk about brand heritage even though its meaning and its difference from related concepts are not entirely clear. Through a review of the multidisciplinary literature, this article distinguishes brand heritage from the concepts of inheritance, retro, nostalgia, and authenticity. This article defines brand heritage as a dynamic construct based on an inherited or borrowed past, with a view to supporting brand identity and being transmitted. A total of 11 research propositions are presented within an inclusive framework that paves the way for future research and contributes to research on brand management and the role of consumers in creating value

Delineamentos para uma teoria da Museologia

The guiding principles in the formulation of a Museology theory were established\ud and disseminated internationally from the mid-1980s, and are related to the creation of the\ud International Committee for Museology (Icofom), associated with the International Council of\ud Museums (Icom). The opinions regarding the nature of so-called museological knowledge\ud were issued under the very specific conditions of each groups composition and of the intellectual\ud work undertook in the occasion. Despite the difficulties with the wording, risen in tandem with\ud the exercise (the terminology problem), we focused on the conjuncture that surrounded the\ud formulation: the environment, the aims, the way in which it was composed and the foundations\ud that characterise it, as well as some of the discussions that took place, which revealed aspects\ud that have been handed down as a legacy in this field of specialization

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Interindividual clinical variability in the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is vast. We report that at least 101 of 987 patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia had neutralizing immunoglobulin G (IgG) autoantibodies (auto-Abs) against interferon-w (IFN-w) (13 patients), against the 13 types of IFN-a (36), or against both (52) at the onset of critical disease; a few also had auto-Abs against the other three type I IFNs. The auto-Abs neutralize the ability of the corresponding type I IFNs to block SARS-CoV-2 infection in vitro. These auto-Abs were not found in 663 individuals with asymptomatic or mild SARS-CoV-2 infection and were present in only 4 of 1227 healthy individuals. Patients with auto-Abs were aged 25 to 87 years and 95 of the 101 were men. A B cell autoimmune phenocopy of inborn errors of type I IFN immunity accounts for life-threatening COVID-19 pneumonia in at least 2.6% of women and 12.5% of men